Bryan Johnson's Biomarkers: The Science and Limits of Biological Age

Tech entrepreneur Bryan Johnson spends two million dollars annually on his "Project Blueprint." The goal: to reduce his biological age and slow the aging process. His protocol involves hundreds of measurements, from whole-body MRIs and blood analyses to epigenetic tests. His published results, including a claimed reduction of his biological age by over five years in just seven months, have electrified the longevity community.

In the media, he is often either hailed as a visionary or dismissed as an eccentric. Both labels obscure the more interesting questions: What exactly do his biomarkers measure? What is the real significance of these values? And what are the scientific limits of an N=1 experiment, where a single individual becomes the measure of all things?

This article provides an evidence-based perspective. We analyze the biomarkers used, explain the science behind them, and show why an isolated measurement can never replace a comprehensive medical diagnosis.

Who is Bryan Johnson and What is His Blueprint Protocol?

Bryan Johnson sold his company, Braintree, to PayPal for $800 million in 2013. Since around 2021, he has dedicated himself full-time to optimizing his health through his "Blueprint" project. He and his team of doctors follow a strictly data-driven approach: nearly every aspect of his body is quantified, from sleep duration and stool frequency to bone density.

His protocol is publicly documented and has inspired many followers. The core of the approach is the continuous measurement of biomarkers to verify the effects of interventions, ranging from diet and exercise to a regimen of over 100 daily supplements.

The Blueprint Protocol: Scope and Methods of Measurement

Johnson's diagnostics combine standard procedures with experimental methods. The main pillars include:

• Blood Biomarkers: Johnson measures over 100 biomarkers monthly. These include classic values like blood lipids and inflammatory markers, but also parameters such as ApoB (Apolipoprotein B) for cardiovascular risk, the HOMA-IR index to determine insulin resistance, and high-sensitivity C-reactive protein (hs-CRP) as a systemic inflammatory marker. This goes far beyond a standard blood panel.
• Imaging: Regular whole-body MRIs, ultrasound scans of organs and vessels, and EKGs to monitor for early signs of tumors or vascular changes.
• Functional Tests: VO₂ max measurement, grip strength tests, balance tests, and cognitive performance tests capture physical and mental capacity.
• Epigenetic Clocks: To determine his biological age, Johnson uses various DNA methylation (DNAm) tests, which are among the best-known but also most controversially discussed biomarkers in longevity research.

This volume of data allows for tracking subtle changes over time. However, data volume and clinical relevance are two different things. The crucial step lies in interpretation, and this is where the scientific debate begins.

Epigenetic Clocks and Biological Age: The Underlying Theory

Our chronological age is the number of years since birth. Biological age, in contrast, is intended to reflect the actual aging status of our cells and organs. Two 50-year-old individuals can have vastly different biological ages, depending on genetics, lifestyle, and environmental factors.

The most popular method for estimating biological age is based on DNA methylation. Imagine your genome as a cookbook: the DNA sequence is the collection of recipes, and methylation consists of small chemical tags that determine which genes are "read" and which are silenced. As we age, this pattern of methylation changes in predictable ways. Epigenetic clocks are algorithms that calculate a biological age from the methylation pattern at hundreds of sites across the genome.

Studies show that individuals with a biological age higher than their chronological age have a measurably increased risk for age-related diseases and higher mortality (Horvath & Raj, Nature Reviews Genetics, 2018).

Differences Between DNAm Clocks: PhenoAge, GrimAge, and Others

"Epigenetic clock" sounds like a single, unified concept. In reality, dozens of different versions exist in research, each trained on different data and measuring slightly different aspects of aging:

• Horvath Clock (2013): The first multi-tissue clock that provides an accurate estimate of chronological age across various cell types. Its strength lies in its broad applicability.
• PhenoAge (2018): This clock was not trained on chronological age but on clinical aging markers like albumin, glucose, and C-reactive protein. It is designed to better reflect health status than calendar age (Levine et al., Aging, 2018).
• GrimAge (2019): Considered one of the most accurate clocks for predicting remaining lifespan. It is based on surrogate markers for plasma proteins strongly associated with mortality and also incorporates smoking status.
• DunedinPACE (2022): This clock doesn't measure a static biological age but rather the current pace of the aging process: how many biological years a person is aging per chronological year.

These clocks are not interchangeable. A person might be biologically younger according to PhenoAge but show an increased risk according to GrimAge. Each clock illuminates a different facet of aging.

How Accurate Are Epigenetic Clocks? A Critical Assessment

The correlation between an elevated epigenetic age and a higher risk of disease and mortality is well-documented in large population studies. However, for individual clinical use, there are significant limitations:

1. Lack of Standardization: Different labs and different clocks can produce different results from the same blood sample. Clinical application requires reproducible and comparable measurements, which are currently lacking.
2. Correlation vs. Causation: An epigenetic clock is a predictor, not proof. Whether the change in the methylation pattern is a cause or a consequence of aging remains an open question. Furthermore, it is not yet scientifically proven that an intervention that lowers epigenetic age automatically reduces disease risk.
3. Probabilistic Statement: An epigenetic value is a statistical probability. A "biological age" of 50 means that the methylation profile resembles that of an average 50-year-old. Nothing more, nothing less. The individual variance is considerable.

Dr. Richard Siow, Director of Ageing Research at King's College London, considers these technologies promising for basic research but still too immature for widespread clinical use as a sole diagnostic marker.

Functional Biomarkers: Grip Strength and VO₂ Max as Solid Predictors

In addition to molecular markers, Johnson also relies on functional tests. These are often better validated and more directly linked to health outcomes.

• Grip Strength: The maximum force of the hand is considered one of the most robust predictors of all-cause mortality. A study in The Lancet with nearly 140,000 participants from 17 countries showed that a 5 kg decrease in grip strength was associated with a 16% increased risk of all-cause mortality (Leong et al., The Lancet, 2015). It serves as a proxy for muscle mass and frailty.
• VO₂ Max: The maximum oxygen uptake during exertion reflects the efficiency of the heart, lungs, and circulatory system. A high VO₂ max is one of the strongest single predictors of a long and healthy life. Unlike many blood values, there is hardly an upper limit to its benefits.

Why Fitness Can Correlate Better with Mortality Than Molecular Markers

Grip strength and VO₂ max are "outcome-proximal": they directly measure what the body can do, a fundamental requirement for an independent life. Their prognostic power has been validated over decades in hundreds of studies involving millions of participants.

DNA methylation is "outcome-distal." It provides clues about underlying processes, but the chain from measurement to actual health outcome is longer and more complex. The most sensible approach combines both: functional tests show what the body can do, while molecular markers help to understand why.

The Limitations of Bryan Johnson's Approach

Johnson's project is impressive in its consistency. From a scientific perspective, however, his approach has fundamental methodological weaknesses that make it difficult to generalize his results.

1. The N=1 Problem: The experiment has a sample size of one. What works for Johnson may not work for others. Without a control group, the effectiveness of individual interventions cannot be objectively assessed.
2. Confounding Variables: Johnson changed dozens of aspects of his life simultaneously: diet, sleep, exercise, supplements, sleep temperature, light exposure. Whether the improvements are due to the vegan diet, the strength training, or one of the 100+ daily pills remains unclear. It is likely the combination, but the contribution of individual parts is unknown.
3. The Surrogate Endpoint Problem: Johnson optimizes for biomarkers in the hope that this will improve his actual health outcomes. Medical history is full of counterexamples: drugs that successfully lowered a biomarker like cholesterol but did not reduce heart attack rates as expected. Whether lowering epigenetic age by five years actually adds five healthy life years is a plausible hypothesis, not a proven fact.
4. The Hawthorne Effect: The act of intense self-monitoring changes behavior. Johnson's extreme monitoring creates a level of discipline that cannot be cleanly separated from the physiological effects of his interventions.

What Actually Works? Evidence-Based Longevity Interventions

You don't have to be a millionaire to pull the most effective levers for a long and healthy life. Most of the interventions Johnson employs are well-researched and accessible to everyone. Improving biomarkers is often a consequence of these changes, not the primary goal.

• Calorie Restriction and Nutrition: Johnson practices a moderate calorie restriction of about 10%. The CALERIE study showed that such a restriction can measurably slow the aging process at an epigenetic level (Wegman et al., The Journals of Gerontology, 2022). A plant-based, nutrient-dense diet forms the foundation.
• Exercise: Regular training that combines endurance, strength, stability, and flexibility is one of the most effective anti-aging interventions. Studies show that physical activity can significantly lower epigenetic age (Voisin et al., Aging Cell, 2021).
• Sleep: Consistent, high-quality sleep is fundamental for cellular repair and hormonal regulation. Chronic sleep deprivation has been shown to accelerate aging processes.
• Stress Management: Chronic stress increases cortisol levels and promotes systemic inflammation, two of the most important drivers of aging.

Biomarkers can play a useful role in this process: as a feedback mechanism and motivational tool to maintain the discipline required for proven lifestyle changes.

From Data Collection to Clinical Strategy: The YEARS Approach

Johnson's experiment primarily provides one thing: a vast amount of raw data. But data alone is not a plan. An isolated biomarker value without clinical context, medical interpretation, and consideration of the overall picture is at best uninteresting and at worst misleading.

Preventive medicine begins where pure data collection ends. At YEARS, we combine the depth of modern diagnostics with expert medical interpretation.

Step 1: Establishing a Solid Baseline with YEARS Core®

Before measuring experimental markers like epigenetic clocks, a solid foundation is needed. The YEARS Core® program establishes this in a single day: 87 handpicked biomarkers and over 25 clinical examinations, specifically chosen for their predictive power for the most common age-related diseases.

• Cardiovascular Risk: with ApoB, hs-CRP, NT-proBNP, and imaging techniques like heart and vessel ultrasounds.
• Metabolic Health: with the HOMA-IR index for early detection of insulin resistance, long before blood sugar becomes abnormal.
• Functional Fitness: with a clinical VO₂ max measurement, muscle strength tests, and balance analyses.
• Early Detection: with AI-supported skin screening (ATBM Master) and comprehensive ultrasound of the abdominal organs and thyroid.

This baseline reveals your current health status and your most important individual risks.

Step 2: Deeper Insights with Evolve® and Ultimate®

For clients who wish to delve deeper into molecular diagnostics, the YEARS Evolve® and Ultimate® programs expand upon the proven Core® methods with the following procedures:

• Whole-Body MRI: Systematic imaging from head to toe to detect structural abnormalities.
• Liquid Biopsy: A blood test (truCheck) that screens for circulating tumor cells from over 70 types of cancer, complementing traditional screening.
• Biological Clocks: Measurement of epigenetic age with various validated clocks for a comprehensive molecular profile.
• Genomics and Microbiomics (Ultimate®): Analysis of the entire exome and genome to identify genetic risks, as well as a detailed examination of the gut flora.

The difference lies in the conclusion: the results are compiled into a 60-page YEARS Health Report and are put into context during a strategy discussion with a physician. This clarifies which values are clinically relevant, which are purely informational, and what concrete action steps can be derived from them.

Conclusion: Biomarkers Are the Map, The Physician is the Navigator

Johnson's Blueprint project has raised awareness for preventive health and the value of data. His approach shows what is possible when resources and discipline are unlimited and how far an N=1 experiment can be pushed.

At the same time, his experiment reveals the limits of pure self-quantification. Data without medical interpretation is noise. Biomarkers are a map of the body—incredibly detailed and valuable—but without an experienced navigator who knows the terrain and keeps the destination in sight, one remains lost.

The future of preventive medicine lies in each person taking responsibility for their health, supported by a medical team that uses state-of-the-art diagnostics to turn data into a clear, actionable strategy. A consultation about your personal risk profile and a sensible diagnostic strategy is the first and most important step on this path.

---

Sources

• Horvath, S., & Raj, K. (2018). DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nature Reviews Genetics, 19(6), 371–384. PubMed
• Leong, D. P., et al. (2015). Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. The Lancet, 386(9990), 266–273. PubMed
• Levine, M. E., et al. (2018). An epigenetic biomarker of aging for lifespan and healthspan. Aging, 10(4), 573–591.
• Lu, A. T., et al. (2019). DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging, 11(2), 303–327. PubMed
• Voisin, S., et al. (2021). An epigenetic clock for physical activity. Aging Cell, 20(3), e13313.
• Wegman, M. P., et al. (2022). Practicality of intermittent fasting in humans and its effect on oxidative stress and genes related to aging and metabolism. The Journals of Gerontology: Series A, 77(9), 1736–1745.